Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
MDU Resources Group, Inc. | MRE | Nov 15, 2024 | 16.80 | -2.33 |
Mears Group PLC | MM7 | Nov 15, 2024 | 4.37 | +1.16 |
Mebuki Financial Group Inc. | 5EE | Nov 15, 2024 | 3.92 | +1.55 |
Medallion Financial Corp. | MD5 | Nov 15, 2024 | 8.85 | -5.35 |
Medapp S.A. | WQ1 | Nov 15, 2024 | 0.03 | +1.92 |
Medaro Mining | 1ZY0 | Nov 15, 2024 | 0.11 | 0.00 |
MEDBRIGHT AI INVTS INC. | Y30 | Nov 15, 2024 | 0.01 | 0.00 |
MedCap | 61MA | Nov 15, 2024 | 46.50 | -0.43 |
Medesis Pharma S.A. | 76D | Nov 15, 2024 | 0.40 | +14.29 |
Medexus Pharmaceuticals Inc | P731 | Nov 15, 2024 | 1.28 | -1.54 |
Media and Games Invest SE | M8G | Nov 15, 2024 | 3.90 | -1.39 |
Mediaco Holding Inc. - Class A | 3WX | Nov 15, 2024 | 1.07 | +2.88 |
MEDIAN POLSKA S.A. ZY-,10 | GY3 | Nov 15, 2024 | 0.15 | 0.00 |
Median Technologies | 4ZG | Nov 15, 2024 | 4.13 | -1.67 |
Mediaseek Inc. | 6WJ | Nov 15, 2024 | 1.60 | 0.00 |
Medibank Private Limited | MPV | Nov 15, 2024 | 2.26 | +1.80 |
Medical Facilities Corp | 31F | Nov 15, 2024 | 10.50 | -3.67 |
Medical Properties Trust Inc | M3P | Nov 15, 2024 | 3.99 | -0.56 |
Mediclin AG | MED | Nov 15, 2024 | 2.50 | +4.17 |
Medicover B | 5M0B | Nov 15, 2024 | 15.20 | +0.26 |
Medicure Inc | NGQ1 | Nov 15, 2024 | 0.54 | 0.00 |
MEDICUS PHARMA LTD. | N46 | Nov 15, 2024 | 0.57 | 0.00 |
MEDICUS PHARMA LTD. | N460 | Nov 15, 2024 | 2.73 | 0.00 |
MEDIFAST INC | MDF | Nov 15, 2024 | 16.72 | -0.36 |
Medigene AG | MDG1 | Nov 15, 2024 | 1.63 | -0.85 |
Medimi | 79T | Nov 15, 2024 | 0.00 | 0.00 |
Medincell S.A. | MEB | Nov 15, 2024 | 17.48 | -1.24 |
MEDIOBANCA S.P.A.UNSP.ADR | ME90 | Nov 15, 2024 | 14.20 | 0.00 |
Mediobanca SpA | ME9 | Nov 15, 2024 | 14.31 | +0.04 |
Medion AG | MDN | Nov 15, 2024 | 14.30 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.